Metropolitan Life Insurance Company (MetLife)’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,811	Closed	-$8.89K	–	2276
2024 Q1	$8.89K	Buy	+1,811	New	+$8.6K	﹤0.01%	2170

Metropolitan Life Insurance Company (MetLife)'s TGAN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 1,811 shares — an estimated $8.89K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TGAN in Q1 2024 and held it in 1 quarter. The position peaked at $8.89K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,811 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $8.89K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Transphorm, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Metropolitan Life Insurance Company (MetLife)'s Transphorm, Inc. Common Stock position peaked at $8.89K in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.